Clinical Pharmacokinetics

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
PHARMACOKINETIC.
1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College March.
Two-compartment model
One-compartment open model: Intravenous bolus administration
Laplace transformation
Week 4 - Biopharmaceutics and Pharmacokinetics
INTRAVENOUS INFUSION.
ADME And PHARMACOKINETICS.
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Analytical Toxicology Pharmacokinetics and Pharmacodynamics.
Pharmacokinetics Introduction
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
Biopharmaceutics refers to the relationship of the:
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
One Compartment Open Model IV bolus
1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College January.
BIOPHARMACEUTICS.
TDM Therapeutic Drug Monitoring
Multicompartment Models
PHT 415 BASIC PHARMACOKINETICS
The General Concepts of Pharmacokinetics and Pharmacodynamics
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
By : Dr. Roshini Murugupillai
Pharmacokinetics 3rd Lecture
Compartmental Models and Volume of Distribution
Pharmacology I Session One Pharmacological Principles.
Pharmacokienetic Principles (2): Distribution of Drugs
BASIC PHARMACOKINETIC PARAMETERS
Physiology for Engineers
Drug therapy in pediatric
Pharmacology Phone Number: (203)
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Pharmaceutics 2.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Kinetics, Modeling Oct 19, 2009 Casarett and Doull,
Dosimetry and Kinetics
Kinetics, Modeling Oct 15, 2006 Casarett and Doull,
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Clinical Pharmacokinetics
Clinical Pharmacokinetics
School of Pharmacy, University of Nizwa
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Pharmacokinetics: Metabolism of Drugs
Conceptual Subdivisions of Pharmacology
Clinical Pharmacokinetics
Conceptual Subdivisions of Pharmacology
Clinical Pharmacokinetics
Hawler Medical University
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Hawler Medical University
School of Pharmacy, University of Nizwa
Therapeutic Drug Monitoring chapter 1 part 1
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Therapeutic Drug Monitoring
Hawler Medical University
Presentation transcript:

Clinical Pharmacokinetics University of Nizwa College of Pharmacy and Nursing School of Pharmacy Clinical Pharmacokinetics PHCY 350 Lecture-4 Pharmacokinetic Models Dr. Sabin Thomas, M. Pharm. Ph. D. Assistant Professor in Pharmacy Practice School of Pharmacy University of Nizwa

Course Outcome Upon completion of this lecture the students will be able to differentiate various compartment models and its importance in clinical practice, classify typical organ groups of Central and Peripheral Compartments, clinically correlate the one compartment and two compartment models with suitable examples.

The handling of a drug by the body can be very complex, as several processes (ADME) work to alter drug concentrations in tissues and fluids. Simplifications of body processes necessary to predict a drugs behavior in the body by applying mathematical principles. A basic model of the body must be selected to apply mathematical principles and that is the Compartment model. Compartmental models are categorized by the number of compartments needed to describe the drug's behavior in the body.

There are one-compartment, two-compartment, and multicompartment models. The compartments do not represent a specific tissue or fluid but may represent a group of similar tissues or fluids. These models can be used to predict the time course of drug concentrations in the body. To construct a compartmental model as a representation of the body, simplifications of body structures are made. Organs and tissues in which drug distribution is similar are grouped into one compartment.

For example, distribution into adipose tissue differs from distribution into renal tissue for most drugs. Therefore, these tissues may be in different compartments. The highly perfused organs (e.g., heart, liver, and kidneys) often have similar drug distribution patterns, so these areas may be considered as one compartment. The compartment that includes blood (plasma), heart, lungs, liver, and kidneys is usually referred to as the central compartment or the highly blood-perfused compartment.

Typical organ groups of Central and Peripheral Compartments Central Compartment Heart Liver Lungs Kidney Blood Peripheral Compartments Fat Tissues Muscle Tissues Cerebrospinal Fluid

The other compartment that includes the fat tissue, muscle tissue, and cerebrospinal fluid is the peripheral compartment, which is less well perfused than the central compartment. If a one-compartment model is sufficient to predict plasma drug concentrations (and those concentrations are of most interest to us), then a more complex (two-compartment or more) model is not needed. However, more complex models are often required to predict tissue drug concentrations. Another simplification of body process is appearance of changes in amount of drug in the body over time (rates). These elimination rate describes the change in amount of drug in the body due to drug elimination over time.

The one-compartment model is the most frequently used model in clinical practice. In structuring the model, a visual representation is helpful. The compartment is represented by an enclosed square or rectangle, and rates of drug transfer are represented by straight arrows. The arrow pointing into the box simply indicates that drug is put into that compartment. And the arrow pointing out of the box indicates that drug is leaving the compartment.

This model is the simplest because there is only one compartment. All body tissues and fluids are considered a part of this compartment. Furthermore, it is assumed that after a dose of drug is administered, it distributes instantaneously to all body areas.

One Compartment Model k X0 X1 Where: X0 = Dose of drug X1 = Amount of drug in body k = Elimination rate constant X1

Clinical Correlate Drugs that do not extensively distribute into extravascular tissues, such as aminoglycosides, are generally well described by one-compartment models. Extent of distribution is partly determined by the chemistry of the agents. Aminoglycosides are polar molecules, so their distribution is limited primarily to extracellular water. Drugs extensively distributed in tissue (such as lipophilic drugs like benzodiazepines) or those that have extensive intracellular uptake may be better described by the more complex models.

Some drugs do not distribute instantaneously to all parts of the body, however, even after intravenous bolus administration. Intravenous bolus dosing means administering a dose of drug over a very short time period. A common distribution pattern is for the drug to distribute rapidly in the bloodstream and to the highly perfused organs, such as the liver and kidneys. Then, at a slower rate, the drug distributes to other body tissues. This pattern of drug distribution may be represented by a two-compartment model. The rapidly distributing tissues are called the central compartment, and the slowly distributing tissues are called the peripheral compartment. Drug moves back and forth between these tissues to maintain equilibrium

Two Compartment Model k X0 X1 K21 K12 X2 where: X0 = dose of drug X1 = amount of drug in central compartment X2 = amount of drug in peripheral compartment K = elimination rate constant of drug from central compartment to outside the body K12 = elimination rate constant of drug from peripheral compartment to central compartment K21 = elimination rate constant of drug from central compartment to peripheral compartment X1 X2

Clinical Correlate Digoxin, particularly when given intravenously, is an example of a drug that is well described by two-compartment pharmacokinetics. After an intravenous dose is administered, plasma concentrations rise and then rapidly decline as drug distributes out of plasma and into muscle tissue. After equilibration between drug in tissue and plasma, plasma concentrations decline less rapidly. The plasma would be the central compartment, and muscle tissue would be the peripheral compartment.

Digoxin Plasma Concentration

Drug Distribution in One & Two-Compartment models

Distribution phase of aminoglycosides is only 15 to 30 minutes and hence one-compartment model can be used. Distribution phase of vancomycin is 1 to 2 hrs and hence two-compartment model can be used. One compartment model is used for tissues that rapidly equilibrate with tissues and two compartment model is used for drugs which slowly equilibrate with tissues.